The Cigna Group

NYQ: CI

Live Quote

📈 ZcoreAI Score

Our AI model analyzes The Cigna Group's price action across multiple timeframes using regression channels and statistical scoring.

Get CI Z-Score →

About The Cigna Group

Healthcare Healthcare Plans

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

📊 Fundamental Analysis

The Cigna Group demonstrates a profit margin of 2.2%, which is below the sector average, suggesting competitive pressure.

The company recently reported 10.4% revenue growth, which is above average for the Healthcare sector.

Return on Equity (ROE) is 15.1%, which suggests room for improvement in capital utilization.

At a current price of $271.25, CI currently sits at the 29th percentile of its 52-week range (Range: $239.51 - $350.00).

💰 Valuation Insight

CI trades at a 51.1% discount (PE: 12.22), which may represent a value opportunity given the sector average of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak

🔴 Debt/Equity Elevated

⚠️ Revenue Growth Moderate

🔴 Return on Equity Weak

✅ Beta (Risk) Low Volatility

Key Financials

Market Cap

$72.46B

Trailing P/E

12.22

Forward P/E

8.11

Beta (5Y)

0.27

52W High

$350.00

52W Low

$239.51

Avg Volume

1.74M

Day High

Day Low

Get CI Z-Score on Dashboard 🚀